Zoe M. Weinstein, MD, MS
Assistant Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine

MD, University of California San Francisco



Zoe M. Weinstein MD,MS, is a general internist and a graduate of the Boston University Addiction Medicine Fellowship. Her research interests include the health of urban underserved patients, especially in the areas of addiction and HIV. Her current clinical work and research are focused on long-term Office-Based Opioid Treatment (OBOT) with buprenorphine, the integration of addiction treatment with primary care and inpatient medical care. She is currently the director of Boston Medical Center’s Addiction Consult Service.

2017 Boston University School of Public Health: Delta Omega Honors Society
2015 American Society of Addiction Medicine : Ruth Fox Scholarship
2015 Association for Medical Education and Research in Substance Abuse: Conference Travel Award
2014 American Society of Addiction Medicine : Next Generation Award
2014 Boston Medical Center: Resident Advocacy Award
2014 Boston Medical Center: John Noble Scholarship



Preventing Bacterial and Viral Infections Among Injection Drug users
09/09/2016 - 04/30/2018 (PI)
Trustees of Boston University NIH-NIDA

Next Generation Award for Adolescent Substance Use Prevention-Zoe Weinstein
07/01/2014 - 06/30/2015 (PI)
American Board of Addiction Medicine Foundation



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817.
     
  2. Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 08 01; 189:166-171.View Related Profiles. PMID: 29958128.
     
  3. Mehta AB, Weinstein Z, Walkey AJ. The Untold Toll of the Opioid Crisis on Intensive Care Units in the United States. Ann Am Thorac Soc. 2017 Dec; 14(12):1763-1765.View Related Profiles. PMID: 29192818.
     
  4. Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 Nov; 82:41-47.View Related Profiles. PMID: 29021114.
     
  5. Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19.View Related Profiles. PMID: 28673522.
     
  6. Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017 Aug; 79:1-5.View Related Profiles. PMID: 28673521.
     
  7. Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Long-term retention in Office Based Opioid Treatment with buprenorphine. J Subst Abuse Treat. 2017 Mar; 74:65-70.View Related Profiles. PMID: 28132702; DOI: 10.1016/j.jsat.2016.12.010;.
     
  8. Schiff DM, Drainoni ML, Bair-Merritt M, Weinstein Z, Rosenbloom D. A Police-Led Addiction Treatment Referral Program in Massachusetts. N Engl J Med. 2016 12 22; 375(25):2502-2503.View Related Profiles. PMID: 28002701; DOI: 10.1056/NEJMc1611640;.
     
  9. Weinstein ZM, Cheng DM, Quinn E, Hui D, Kim H, Gryczynski G, Samet JH. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend. 2017 Jan 01; 170:9-16.View Related Profiles. PMID: 27865152; DOI: 10.1016/j.drugalcdep.2016.10.039;.
     
  10. Thakarar K, Weinstein ZM, Walley AY. Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J. 2016 Jun; 92(1088):356-63.View Related Profiles. PMID: 27004476; PMCID: PMC4967553; DOI: 10.1136/postgradmedj-2015-133720;.
     
Showing 10 of 11 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 11 publications over 3 distinct years, with a maximum of 5 publications in 2016

YearPublications
20165
20174
20182
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

substance use; primary care; buprenorphine; addiction consult service

Zoe Weinstein MD, MS has mentored medical students in the summer research program as well as longitudinally, resulting in national oral presentations and multiple publications including at least one first author publication. She also mentors residents and fellows in research projects which have resulted in national oral presentations and publications. She actively mentors residents and fellows who are interested in careers in primary care and addiction medicine.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Weinstein's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department